Search Results
Oct 02, 2025, 22:17 ET PEI-제네시스, 서울 ADEX 2025 참가
예정이다. PEI-제네시스는 올해에도 최고의 산업 전시회에 참가하여 항공우주, 방위, 기타 까다로운 산업 분야에서 사용하기 적합하고 우수한 신뢰성을 보장하는 각종 커넥터를 선보일 예정이다. 이번 전시회에서는 암페놀(Amphenol), ITT Cannon, Souriau by Eaton, Cinch, Conesys, PRECI-DIP의 내구성 강한 군용(MIL-DTL-38999 및 MIL-DTL-5015 원형 커넥터 등), RF(고주파), 광섬유 및 극한 조건용 커넥터가 전시될 예정이다.. 특히 암페놀의 RF
More news about: PEI-Genesis
Oct 02, 2025, 12:00 ET Frazier Aviation Bolsters Business Development and Operational Capabilities with Expanded Senior Management Team
Blanc joins Frazier as Manager of Operations and Supply Chain. Blanc previously held senior operations and fabrication management roles at RTC Aerospace, ITT Aerospace Control, and Halo Industries. At Frazier Aviation, he will provide hands-on leadership to optimize manufacturing capacity and reduce lead times
More news about: Frazier Aviation, Inc.
Sep 24, 2025, 10:01 ET Global Water Pump Market Set to Reach USD 58.18 Billion by 2030 | Regional Breakdowns, Industry Segments, and Future Trends: MarkNtel Advisors
2030 Flowserve Corporation | Pentair PLC | Sulzer Limited | Kirloskar Brothers Limited (KBL) | Grundfos | Xylem Inc | KSB Group | Wilo | ITT Inc. | Torishima Pump MFG. Co. Ltd | Other Players Recent Developments: 2024, Atlas Copco
More news about: MarkNtel Advisors
Sep 22, 2025, 22:56 ET Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation
and clinically meaningful improvements in PFS for ivonescimab plus chemotherapy compared to tislelizumab plus chemotherapy. In the intent-to-treat (ITT) population, patients receiving ivonescimab plus chemotherapy showed significantly superior PFS benefits compared to the control group. This PFS improvement
More news about: Akeso, Inc.
Sep 17, 2025, 19:30 ET Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
1 summarizes efficacy results from the Phase III study versus placebo (intent-to-treat, ITT analysis). Table 1. Efficacy results from the Phase III study versus placebo (intent-to-treat, ITT analysis)
More news about: Ascletis Pharma Inc.
Sep 15, 2025, 02:04 ET PEI-Genesis to Exhibit at India International Railway Equipment Exhibition (IREE) 2025 in New Delhi
trusted in the rail industry, including: Positronic D-Sub – Durable, high-density rectangular connectorsITT VEAM FRCIR290 – IP67, Rugged circular bayonet connector for power & data connectionsAmphenol GT – Heavy-duty circular connectors
More news about: PEI-Genesis